RÉSUMÉ
High extracellular matrix (ECM) content in solid cancers impairs tumour perfusion and thus access of imaging and therapeutic agents. We have devised a new approach to degrade tumour ECM, which improves uptake of circulating compounds. We target the immune-modulating cytokine, tumour necrosis factor alpha (TNFα), to tumours using a newly discovered peptide ligand referred to as CSG. This peptide binds to laminin-nidogen complexes in the ECM of mouse and human carcinomas with little or no peptide detected in normal tissues, and it selectively delivers a recombinant TNFα-CSG fusion protein to tumour ECM in tumour-bearing mice. Intravenously injected TNFα-CSG triggered robust immune cell infiltration in mouse tumours, particularly in the ECM-rich zones. The immune cell influx was accompanied by extensive ECM degradation, reduction in tumour stiffness, dilation of tumour blood vessels, improved perfusion and greater intratumoral uptake of the contrast agents gadoteridol and iron oxide nanoparticles. Suppressed tumour growth and prolonged survival of tumour-bearing mice were observed. These effects were attainable without the usually severe toxic side effects of TNFα.
Sujet(s)
Matrice extracellulaire/métabolisme , Animaux , Lignée cellulaire , Techniques d'exposition à la surface cellulaire , Produits de contraste/métabolisme , Femelle , Composés du fer III/métabolisme , Gadolinium/métabolisme , Composés hétérocycliques/métabolisme , Humains , Mâle , Souris , Nanoparticules/métabolisme , Composés organométalliques/métabolisme , Facteur de nécrose tumorale alpha/métabolismeRÉSUMÉ
Repeated experimental reinfection of two subjects indicates that Helicobacter pylori infection does not promote an immune response protective against future reinfection. Our results highlight the importance of preventing reinfection after eradication, through public health initiatives, and possibly treatment of family members. They indicate difficulties for vaccine development, especially therapeutic vaccines.
RÉSUMÉ
As a general strategy to selectively target antibody activity in vivo, a molecular architecture was designed to render binding activity dependent upon proteases in disease tissues. A protease-activated antibody (pro-antibody) targeting vascular cell adhesion molecule 1 (VCAM-1), a marker of atherosclerotic plaques, was constructed by tethering a binding site-masking peptide to the antibody via a matrix metalloprotease (MMP) susceptible linker. Pro-antibody activation in vitro by MMP-1 yielded a 200-fold increase in binding affinity and restored anti-VCAM-1 binding in tissue sections from ApoEâ»/â» mice ex vivo. The pro-antibody was efficiently activated by native proteases in aorta tissue extracts from ApoEâ»/â», but not from normal mice, and accumulated in aortic plaques in vivo with enhanced selectivity when compared to the unmodified antibody. Pro-antibody accumulation in aortic plaques was MMP-dependent, and significantly inhibited by a broad-spectrum MMP inhibitor. These results demonstrate that the activity of disease-associated proteases can be exploited to site-specifically target antibody activity in vivo.
Sujet(s)
Anticorps monoclonaux/administration et posologie , Systèmes de délivrance de médicaments , Matrix metalloproteinase 1/administration et posologie , Plaque d'athérosclérose/métabolisme , Promédicaments/administration et posologie , Molécule-1 d'adhérence des cellules vasculaires/immunologie , Animaux , Anticorps monoclonaux/métabolisme , Anticorps monoclonaux/pharmacocinétique , Aorte/métabolisme , Apolipoprotéines E/déficit , Apolipoprotéines E/génétique , Lignée cellulaire , Maladie des artères coronaires/métabolisme , Maladie des artères coronaires/anatomopathologie , Modèles animaux de maladie humaine , Cellules HEK293 , Humains , Matrix metalloproteinase 1/métabolisme , Matrix metalloproteinase 1/pharmacocinétique , Souris , Souris de lignée BALB C , Souris de lignée C57BL , Souris knockout , Distribution tissulaire , Molécule-1 d'adhérence des cellules vasculaires/métabolismeRÉSUMÉ
Peptides are increasingly used as therapeutic and diagnostic agents. The combination of bacterial cell-surface display peptide libraries with magnetic- and fluorescence-activated cell sorting technologies provides an efficient and highly effective methodology to identify and engineer peptides for a growing number of molecular recognition applications. Here, detailed protocols for both the generation and screening of bacterial display peptide libraries are presented. The methods described enable the discovery and evolutionary optimization of protein-binding peptides, cell-specific peptides, and enzyme substrates for diverse biotechnology applications.
Sujet(s)
Découverte de médicament/méthodes , Escherichia coli/composition chimique , Cytométrie en flux/méthodes , Banque de peptides , Peptides/composition chimique , ADN/composition chimique , Colorants fluorescents/composition chimique , Vecteurs génétiques/composition chimique , Humains , Peptides/isolement et purification , Peptides/normes , Plasmides/composition chimique , Liaison aux protéines , Ingénierie des protéines/méthodes , Ingénierie des protéines/normes , Spécificité d'espèce , Spécificité du substratRÉSUMÉ
The enzymatic activity of Helicobacter pylori's urease neutralises stomach acidity, thereby promoting infection by this pathogen. Urease protein has also been found to interact with host cells in vitro, although this property's possible functional importance has not been studied in vivo. To test for a role of the urease surface in the host/pathogen interaction, surface exposed loops that display high thermal mobility were targeted for inframe insertion mutagenesis. H. pylori expressing urease with insertions at four of eight sites tested retained urease activity, which in three cases was at least as stable as was wild-type urease at pH 3. Bacteria expressing one of these four mutant ureases, however, failed to colonise mice for even two weeks, and a second had reduced bacterial titres after longer term (3 to 6 months) colonisation. These results indicate that a discrete surface of the urease complex is important for H. pylori persistence during gastric colonisation. We propose that this surface interacts directly with host components important for the host-pathogen interaction, immune modulation or other actions that underlie H. pylori persistence in its special gastric mucosal niche.
Sujet(s)
Adhérence bactérienne , Protéines bactériennes/métabolisme , Helicobacter pylori/enzymologie , Urease/métabolisme , Animaux , Protéines bactériennes/composition chimique , Protéines bactériennes/génétique , Sites de fixation/génétique , Stabilité enzymatique , Acide gastrique/métabolisme , Muqueuse gastrique/métabolisme , Muqueuse gastrique/microbiologie , Helicobacter pylori/génétique , Interactions hôte-pathogène , Concentration en ions d'hydrogène , Souris , Souris de lignée C57BL , Modèles moléculaires , Mutation , Structure tertiaire des protéines , Estomac/microbiologie , Propriétés de surface , Urease/composition chimique , Urease/génétiqueRÉSUMÉ
Novel plasmids were constructed for the analysis of DNA fragments from the rumen bacterium Pseudobutyrivibrio ruminis. Five previously unidentified promoters were characterized using a novel primer extension method to identify transcription start sites. The genes downstream of these promoters were not identified, and their activity in expression of genomic traits in wild-type P. ruminis remains putative. Comparison with promoters from this and closely related species revealed a consensus sequence resembling the binding motif for the RNA polymerase sigma(70)-like factor complex. Consensus -35 and -10 sequences within these elements were TTGACA and ATAATATA respectively, interspaced by 15-16 bp. The consensus for the -10 element was extended by one nucleotide upstream and downstream of the standard hexamer (indicated in bold). Promoter strengths were measured by reverse transcription quantitative PCR and beta-glucuronidase assays. No correlation was found between the composition and context of elements within P. ruminis promoters, and promoter strength. However, a mutation within the -35 element of one promoter revealed that transcriptional strength and choice of transcription start site were sensitive to this single nucleotide change.